Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.

MLA

Shimakawa, Yusuke, et al. “Hepatitis B Core-Related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 70, no. 7, Mar. 2020, pp. 1442–52. EBSCOhost, https://doi.org/10.1093/cid/ciz412.

APA

Shimakawa, Y., Ndow, G., Njie, R., Njai, H. F., Takahashi, K., Akbar, S. M. F., Cohen, D., Nayagam, S., Jeng, A., Ceesay, A., Sanneh, B., Baldeh, I., Imaizumi, M., Moriyama, K., Aoyagi, K., D’Alessandro, U., Mishiro, S., Chemin, I., Mendy, M., … Lemoine, M. (2020). Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 70(7), 1442–1452. https://doi.org/10.1093/cid/ciz412

Chicago

Shimakawa, Yusuke, Gibril Ndow, Ramou Njie, Harr Freeya Njai, Kazuaki Takahashi, Sheikh Mohammad Fazle Akbar, Damien Cohen, et al. 2020. “Hepatitis B Core-Related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 70 (7): 1442–52. doi:10.1093/cid/ciz412.